X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA TORRENT PHARMA ALEMBIC PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 28.5 29.7 95.8% View Chart
P/BV x 6.5 5.7 115.0% View Chart
Dividend Yield % 0.7 1.0 75.2%  

Financials

 ALEMBIC PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
TORRENT PHARMA
Mar-17
ALEMBIC PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs7921,768 44.8%   
Low Rs4431,186 37.4%   
Sales per share (Unadj.) Rs167.0346.1 48.3%  
Earnings per share (Unadj.) Rs38.255.2 69.2%  
Cash flow per share (Unadj.) Rs42.073.3 57.3%  
Dividends per share (Unadj.) Rs4.0014.00 28.6%  
Dividend yield (eoy) %0.60.9 68.3%  
Book value per share (Unadj.) Rs84.9257.1 33.0%  
Shares outstanding (eoy) m188.52169.22 111.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.74.3 86.6%   
Avg P/E ratio x16.226.8 60.4%  
P/CF ratio (eoy) x14.720.1 73.0%  
Price / Book Value ratio x7.35.7 126.6%  
Dividend payout %10.525.4 41.3%   
Avg Mkt Cap Rs m116,383249,887 46.6%   
No. of employees `000NA11.8 0.0%   
Total wages/salary Rs m4,2149,934 42.4%   
Avg. sales/employee Rs ThNM4,971.5-  
Avg. wages/employee Rs ThNM843.2-  
Avg. net profit/employee Rs ThNM792.4-  
INCOME DATA
Net Sales Rs m31,48758,569 53.8%  
Other income Rs m552,233 2.5%   
Total revenues Rs m31,54260,802 51.9%   
Gross profit Rs m10,06013,773 73.0%  
Depreciation Rs m7223,069 23.5%   
Interest Rs m372,056 1.8%   
Profit before tax Rs m9,35610,881 86.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1601,545 139.8%   
Profit after tax Rs m7,1949,336 77.1%  
Gross profit margin %31.923.5 135.9%  
Effective tax rate %23.114.2 162.6%   
Net profit margin %22.815.9 143.3%  
BALANCE SHEET DATA
Current assets Rs m15,06653,841 28.0%   
Current liabilities Rs m7,67431,612 24.3%   
Net working cap to sales %23.538.0 61.8%  
Current ratio x2.01.7 115.3%  
Inventory Days Days6797 68.9%  
Debtors Days Days4184 48.5%  
Net fixed assets Rs m8,23742,079 19.6%   
Share capital Rs m377846 44.6%   
"Free" reserves Rs m15,41642,655 36.1%   
Net worth Rs m16,00543,501 36.8%   
Long term debt Rs m022,408 0.0%   
Total assets Rs m24,594101,250 24.3%  
Interest coverage x255.26.3 4,055.7%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.6 221.3%   
Return on assets %29.411.3 261.3%  
Return on equity %44.921.5 209.4%  
Return on capital %58.719.6 298.9%  
Exports to sales %55.70-   
Imports to sales %10.40-   
Exports (fob) Rs m17,551NA-   
Imports (cif) Rs m3,283NA-   
Fx inflow Rs m17,81120,066 88.8%   
Fx outflow Rs m5,3185,304 100.3%   
Net fx Rs m12,49314,762 84.6%   
CASH FLOW
From Operations Rs m9,30410,127 91.9%  
From Investments Rs m-3,105-7,869 39.5%  
From Financial Activity Rs m-1,959-1,918 102.1%  
Net Cashflow Rs m4,240212 2,004.7%  

Share Holding

Indian Promoters % 74.1 71.5 103.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 7.0 41.3%  
FIIs % 9.1 12.6 72.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 8.8 158.0%  
Shareholders   49,328 26,511 186.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  BIOCON LTD  J.B.CHEMICALS  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Airtel, Idea Down by 5%(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 24, 2018 03:11 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - SHASUN PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS